AIMS: To describe the effects of the COVID-19 pandemic on adults with T1D or T2D in the U.S. METHODS: Participants, recruited from the Taking Control of Your Diabetes Research Registry, were &#8805;19â¯years old and diagnosed with either T1D or T2D for &#8805;12â¯months. Participants completed an online survey on a HIPAA-protected platform. RESULTS: Completed surveys were received from 763 T1Ds and 619 T2Ds. Average T1D age was 53.3 (SDâ¯=â¯15.3); average T2D age was 64.9 (SDâ¯=â¯10.3). Both samples were predominantly female, non-Hispanic white and well-educated. Average self-reported HbA1c was 6.9 (SDâ¯=â¯1.0; 52â¯mmol/mol) for T1Ds and 7.1 (SDâ¯=â¯1.1; 54â¯mmol/mol) for T2Ds. About 40% of respondents reported that all of their diabetes healthcare appointments at the time were cancelled or postponed, 40% reported a switch to telehealth appointments and almost half reported lower overall satisfaction with these visits (compared to pre-pandemic). There were widespread increases in general and diabetes-related stress and social isolation, and negative effects on disease management. About 25% reported increases in highs, lows, and glucose variability in both groups. CONCLUSION: There has been a substantive increase in level of diabetes-related and general life stress and social isolation due to the pandemic, with a significant impact on disease management.
The early impact of the COVID-19 pandemic on adults with type 1 or type 2 diabetes: A national cohort study